Physician profile
John Todd
NPI 1528055142
$4,997.27
in general payments reported to CMS, 2019-2025
13 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,033 · 2020: $129 · 2021: $3,127 · 2023: $193 · 2024: $200 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $2,050.00 | 2019-2021 | |
| Exactech, INC. | $1,865.21 | 2021 | |
| Smith+Nephew, INC. | $274.30 | 2021-2025 | Evos, Intellio Link Werewolf, Kvac |
| Depuy Synthes Sales INC. | $184.18 | 2019-2024 | Fms, Vapr, Orthovisc |
| Zimmer Biomet Holdings, INC. | $140.31 | 2023 | Persona |
| Prime Surgical, LLC | $117.34 | 2020 | |
| Carlsmed, INC. | $100.46 | 2025 | Aprevo |
| Acumed LLC | $95.57 | 2019-2023 | Acumed |
| Orthalign INC | $74.66 | 2025 | Orthalign Plus |
| Djo, LLC | $41.98 | 2019-2023 | Cmf |
| Heron Therapeutics, INC. | $21.44 | 2025 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $17.74 | 2019 | |
| Allergan, INC. | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.